Dissertation > Excellent graduate degree dissertation topics show
Silencing of the EGFR Gene by siRNA Effects on Sensitivity of Chemotherapy in MDA-MB-231 Cell Line
Author: WangWei
Tutor: HuangZuo
School: Huazhong University of Science and Technology
Course: Mammary gland thyroid surgery
Keywords: breast cancer EGFR RNAi
CLC: R737.9
Type: Master's thesis
Year: 2011
Downloads: 38
Quote: 0
Read: Download Dissertation
Abstract
|
Objective Studying the expression level of EGFR in Triple negative breast cancer affecting on sensitivity of chemotherapy in vitro, so as to provide a more effective predictor for the choice of chemotherapy drugs and to supply a more rational basis for the individual treatment for breast cancer.Method Since human breast cancer cell line MDA-MB-231 confirmed amplification of EGFR, we have used siRNA to interfere in the expression of EGFR in MDA-MB-231 cell line. And the effect of silence has been tested in the two levels of gene and protein by Real-time PCR and Western-blot. The influence of different EGFR expression after gene silencing made on sensitivity of doxorubicin、docetaxel and 5-Fu was tested by CCK-8 separately.Result For MDA-MB-231 cell line, the inhibition of EGFR gene was 40% by siRNA. Compare the high expression of EGFR group with the low expression of EGFR group about the sensitivity of chemotherapy in MDA-MB-231, and the IC50 of doxorubicin was 0.52±0.13vs0.22±0.06μg/ml, of docetaxel was 2.41±0.78vs2.05±0.55μg/ml and of 5-Fu was 18.9±4.05vs19.3±4.21μg/ml.Conclusion For MDA-MB-231 cell line, silencing of EGFR gene can improve chemotherapy sensitivity of anthracycline significantly, but docetaxel and 5-Fu were not significantly improved.
|
Related Dissertations
- The Effects of Pu-erh Tea on Prevetion and Treatment of Tumor,R285.5
- The Related Study of Breast-conserving Surgery Plus Postoperative Tangential Irradiation,R737.9
- The Relevance Research between Breast Cancer Calcification X Performance and Pathology,R737.9
- Comparative Analysis on CTF and CEF Regimens as Postoperative Adjuvant Chemotherapy in the Treatment of Phase Ⅱ Breast Cancer,R737.9
- The Correlation of Ultrasound Elasticity with the Expressions of Estrogen Receptor, Progestron Receptor, C-erbB-2 in Breast Cancer,R445.1
- Expressions of HOXA9 HOXA10 and HOXA11 in Breast Cancer,R737.9
- The Feasibility of the Immunohistochemistry Classification to Predicting Prognosis in Breast Cancer,R737.9
- The Experimental Study of Antiangiogenic and Induction of Apoptosis by Maximum Tolerated Dose Combined with Low-dose Cyclophosphamide in Breast Cancer,R737.9
- Maximum Tolerated Dose Combined with Metronomic Chemoterpy on Proliferation and Angiogenesis in Treatment of Breast Cancer,R737.9
- The Expression and Significance of Parathyroid Hormone-related Protein in Human Breast Cancer with Skeletal Metastases,R737.9
- The Shrink Pattern of Breast Cancer After Neoadjuvant Chemotherapy and the Correlation with Partial Clinic Pathological Factors: Preliminary Results of a Plot Study,R737.9
- Analysis of Clinial and Patholgoic Characteristics between the Han and the Uygur Patients with Triple-negative Breast Cancer,R737.9
- Clinical Signifinance of Combined Detection of Tumor Markers in Breast Cancer,R737.9
- Protein Expressions of EGFR、K-ras、P53 and Ki-67 in Colorectal Cancer, Gastric Cancer and Esophageal Cancer,R735
- Ginsenoside Rg3 combined IRESSA on human A431 cell growth,R285.5
- Application Evaluation normal serum creatinine glomerular filtration rate in patients with chronic heart failure, renal function,R541.61
- Isoflavone intake and the risk of breast and prostate cancer Meta-analysis,R737.25
- Mammographic X-ray analysis of false-negative breast cancer,R737.9
- Epidermal growth factor in breast carcinoma and its clinical significance 1,2,R737.9
- CK5 / 6 and EGFR as triple negative breast cancer prognostic factors analysis,R737.9
- Association of TGFB1 and TGFBR2 Polymorphisms with Breast Cancer Risk,R737.9
CLC: > Medicine, health > Oncology > Genitourinary tumors > Breast tumor
© 2012 www.DissertationTopic.Net Mobile
|